Zobrazeno 1 - 10
of 395
pro vyhledávání: '"S Sukhanov"'
Publikováno v:
Juvenis Scientia, Vol 9, Iss 1, Pp 24-42 (2023)
The review article discusses modern aspects of drug-induced liver injury (DILI) in patients with tuberculosis who are receiving etiotropic therapy. The main mechanisms of DILI, including toxic and idiosyncratic types, are described, as well as their
Externí odkaz:
https://doaj.org/article/0c1a6065e1094b65b228d3e03c4c3874
Autor:
S. E. Nikitin, S. Nishimoto, Y. Fan, J. Wu, L. S. Wu, A. S. Sukhanov, M. Brando, N. S. Pavlovskii, J. Xu, L. Vasylechko, R. Yu, A. Podlesnyak
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-7 (2021)
A field-induced incommensurate spin density wave order was observed in the spin-chain material YbAlO3; however, its mechanism is not fully understood. Here, using neutron scattering and numerical calculations, the authors propose a mechanism based on
Externí odkaz:
https://doaj.org/article/555d633b9e91448d8fe792e028213704
Autor:
M. G. Romantsov, T. V. Sologub, L. G. Goryacheva, S. N. Kovalenko, D. S. Sukhanov, A. A. Shuldyakov, A. N. Bondarenko, A. L. Kovalenko, A. YU. Petrov
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 3-4, Pp 45-55 (2020)
The aspects of virus hepatitis C immunopathogenesis are discussed. The main attention is paid to higher production of Th1 cytokines providing active protection of the host from HCV. The up-to-date approaches to the therapy of chronic hepatitis C, des
Externí odkaz:
https://doaj.org/article/2483971c6eee4b92a5a03fd48bd27909
Autor:
D. S. Sukhanov, T. I. Vinogradova, N. V. Zabolotnykh, A. L. Kovalenko, S. N. Vasilyeva, M. G. Romantsov
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 1-2, Pp 13-17 (2020)
The hepatoprotective activity of remaxol, reamberin and ademethionine was studied on a model of the liver Injury Induced by antituberculosis drugs. The study included 30 male uninbred albino rats. The following antituberculosis drugs were used: isoni
Externí odkaz:
https://doaj.org/article/efbec254b81045a5b528dc353dd6f16b
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 3-4, Pp 33-36 (2020)
The use of reamberin for prophylaxis of side effects was estimated In 257 patients with tuberculosis of the respiratory organs under the chemotherapy. The reference group involved 241 patients treated with the chemotherapeutics alone. Reamberin in th
Externí odkaz:
https://doaj.org/article/3c300303041148bb94a4a37bd76a0b08
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 5-6, Pp 49-54 (2020)
Interferon inductors of various chemical groups, belonging to antivirals, and induction of several types of endogenous interferon in blood serum are described. Cycloferon was shown efficient in the complex treatment of chronic hepatitis C, tuberculos
Externí odkaz:
https://doaj.org/article/e9f4fd9b848d41b59d78a0f5e3959d60
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 1-2, Pp 13-18 (2020)
The efficacy of reamberin, remaxol, S-adenosyl-L-methionine (ademethionine) and 5% glucose solution was estimated in the treatment of patients with tuberculosis of the respiratory organs and drug hepatotoxicity signs confirmed by higher activity of l
Externí odkaz:
https://doaj.org/article/3541fcec7a044f4b9f2523151911f74f
Publikováno v:
Антибиотики и Химиотерапия, Vol 57, Iss 5-6, Pp 41-52 (2020)
At present, the conception of the use, efficacy and safety of hepatotropic agents in treatment of drug-induced liver injury, in particular due to antituberculosis drugs is not yet final, which is conditioned by extremely rare clinical trials on the s
Externí odkaz:
https://doaj.org/article/6e5682f494ec41dab4f14c3b10bb1a18
Autor:
D. S. Sukhanov, T. I. Vinogradova, A. V. Elkin, N. V. Zabolotnykh, S. N. Vasilyeva, M. L. Vitovskaya
Publikováno v:
Антибиотики и Химиотерапия, Vol 57, Iss 1-2, Pp 17-22 (2020)
Efficacy of remaxol In complex chemotherapy of generalized drug resistant tuberculosis was studied on mice. Mycobacterium tuberculosis 5419 SPBNIIF isolated from a patient with freshey diagnosticated pulmonary tuberculosis resistant to isoniazid (10
Externí odkaz:
https://doaj.org/article/7a15c8018db44d36b462efbe2d549670
Publikováno v:
Антибиотики и Химиотерапия, Vol 57, Iss 11-12, Pp 33-41 (2020)
The available drugs for the treatment of chronic liver affections (the adequate model is chronic hepatitis C) include agents of metabolic therapy, whose efficacy is not always enough, that required the search for original mitochondrial substrates on
Externí odkaz:
https://doaj.org/article/c865a1e0b228451e819e6a29def5370f